These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1289 related items for PubMed ID: 15191204

  • 41. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study].
    Doubremelle M, Bourreille A, Zerbib F, Heresbach D, Metman EH, Beau P, Gournay J, Galmiche JP.
    Gastroenterol Clin Biol; 2002 Nov; 26(11):973-9. PubMed ID: 12483127
    [Abstract] [Full Text] [Related]

  • 42. CD19+ in intestinal mucosa predict the response to infliximab in Crohn's disease.
    Ferkolj I, Ihan A, Markovic S.
    Hepatogastroenterology; 2005 Nov; 52(64):1128-33. PubMed ID: 16001645
    [Abstract] [Full Text] [Related]

  • 43. Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.
    Fasanmade AA, Adedokun OJ, Blank M, Zhou H, Davis HM.
    Clin Ther; 2011 Jul; 33(7):946-64. PubMed ID: 21741088
    [Abstract] [Full Text] [Related]

  • 44. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients.
    Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ.
    Am J Gastroenterol; 2001 Mar; 96(3):722-9. PubMed ID: 11280541
    [Abstract] [Full Text] [Related]

  • 45. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
    Feagan BG, Enns R, Fedorak RN, Panaccione R, Paré P, Steinhart AH, Wild G.
    Can J Clin Pharmacol; 2001 Mar; 8(4):188-98. PubMed ID: 11743591
    [Abstract] [Full Text] [Related]

  • 46. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children.
    Mahdi G, Israel DM, Hassall E.
    Am J Gastroenterol; 1996 Jul; 91(7):1355-9. PubMed ID: 8677994
    [Abstract] [Full Text] [Related]

  • 47. Infliximab (Remicade), a new biological treatment for Crohn's disease.
    D'Haens GR.
    Ital J Gastroenterol Hepatol; 1999 Jul; 31(6):519-20. PubMed ID: 10575573
    [Abstract] [Full Text] [Related]

  • 48. Clinical experience with infliximab therapy in 100 patients with Crohn's disease.
    Farrell RJ, Shah SA, Lodhavia PJ, Alsahli M, Falchuk KR, Michetti P, Peppercorn MA.
    Am J Gastroenterol; 2000 Dec; 95(12):3490-7. PubMed ID: 11151882
    [Abstract] [Full Text] [Related]

  • 49. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 50. Long-term outcome of non-fistulizing (ulcers, stricture) perianal Crohn's disease in patients treated with infliximab.
    Bouguen G, Trouilloud I, Siproudhis L, Oussalah A, Bigard MA, Bretagne JF, Peyrin-Biroulet L.
    Aliment Pharmacol Ther; 2009 Oct; 30(7):749-56. PubMed ID: 19583709
    [Abstract] [Full Text] [Related]

  • 51. Magnetic resonance imaging of the effects of infliximab on perianal fistulizing Crohn's disease.
    Van Assche G, Vanbeckevoort D, Bielen D, Coremans G, Aerden I, Noman M, D'Hoore A, Penninckx F, Marchal G, Cornillie F, Rutgeerts P.
    Am J Gastroenterol; 2003 Feb; 98(2):332-9. PubMed ID: 12591051
    [Abstract] [Full Text] [Related]

  • 52. Therapeutic efficacy of infliximab on patients with short duration of Crohn's disease: a Japanese multicenter survey.
    Matsumoto T, Iida M, Motoya S, Haruma K, Suzuki Y, Kobayashi K, Ito H, Miyata M, Kusunoki M, Chiba T, Yamamoto S, Hibi T.
    Dis Colon Rectum; 2008 Jun; 51(6):916-23. PubMed ID: 18322754
    [Abstract] [Full Text] [Related]

  • 53. Maintenance of medically induced remission of Crohn's disease.
    Gonvers JJ, Juillerat P, Mottet C, Pittet V, Felley C, Vader JP, Michetti P, Froehlich F.
    Digestion; 2007 Jun; 76(2):116-29. PubMed ID: 18239403
    [Abstract] [Full Text] [Related]

  • 54. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A, Annaloro C, Ardizzone S, Onida F, Della Volpe A, Clerici M, Usardi P, Greco S, Maconi G, Porro GB, Deliliers GL.
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [Abstract] [Full Text] [Related]

  • 55. [Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].
    Bermejo F, López San Román A, Algaba A, van Domselaar M, Carneros JA, Rivero M, Piqueras B, Valer MP.
    Gastroenterol Hepatol; 2008 Dec; 31(10):629-32. PubMed ID: 19174078
    [Abstract] [Full Text] [Related]

  • 56. Clinical outcome of Crohn's disease treated with infliximab.
    Arslan S, Kav T, Besisik F, Kaymakoglu S, Pinarbasi B, Tözün N, Hamzaoglu HO, Duman D, Ulker A, Parlak E, Palabiyikoglu M, Dökmeci A.
    Hepatogastroenterology; 2003 Dec; 50(52):952-6. PubMed ID: 12845957
    [Abstract] [Full Text] [Related]

  • 57. Rapid improvement of bone metabolism after infliximab treatment in Crohn's disease.
    Franchimont N, Putzeys V, Collette J, Vermeire S, Rutgeerts P, De Vos M, Van Gossum A, Franchimont D, Fiasse R, Pelckmans P, Malaise M, Belaiche J, Louis E.
    Aliment Pharmacol Ther; 2004 Sep 15; 20(6):607-14. PubMed ID: 15352908
    [Abstract] [Full Text] [Related]

  • 58. Effect of concurrent elemental diet on infliximab treatment for Crohn's disease.
    Tanaka T, Takahama K, Kimura T, Mizuno T, Nagasaka M, Iwata K, Nakano H, Muramatsu M, Takazoe M.
    J Gastroenterol Hepatol; 2006 Jul 15; 21(7):1143-9. PubMed ID: 16824066
    [Abstract] [Full Text] [Related]

  • 59. Infliximab for pediatric ulcerative colitis: a retrospective Italian multicenter study.
    Cucchiara S, Romeo E, Viola F, Cottone M, Fontana M, Lombardi G, Rutigliano V, de'Angelis GL, Federici T.
    Dig Liver Dis; 2008 Jul 15; 40 Suppl 2():S260-4. PubMed ID: 18598998
    [Abstract] [Full Text] [Related]

  • 60. Infliximab in Crohn's disease: first anniversary clinical experience.
    Cohen RD, Tsang JF, Hanauer SB.
    Am J Gastroenterol; 2000 Dec 15; 95(12):3469-77. PubMed ID: 11151879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 65.